NovaDel Pharma Reports Second Fiscal Quarter Results

NovaDel Pharma Inc. (AMX: NVD) reported results for its second fiscal quarter ended January 31, 2006. For the three months ended January 31, 2006, the net loss was $2.8 million, or seven cents per share, compared to a net loss of $2.6 million, or eight cents per share, in the same period last year. Increased research and development expenses in the second quarter of fiscal 2006 were driven by expenditures related to the development of the company’s product pipeline.

MORE ON THIS TOPIC